Qiagen Q1 Sales Rise 4 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Qiagen reported after the close of the market Tuesday that its first quarter sales increased 4 percent year over year with growth across all regions and customer classes.

The firm reported total sales of $317.1 million for the three months ended March 31, up from $303.6 million. On an adjusted basis, its sales for the quarter were up 5 percent to $317.4 million at constant exchange rates. It beat the consensus Wall Street estimate of $316.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.